ContributorsPublishersAdvertisers

#Pfizer Inc

U.S. travel stocks jump as new vaccine data eases Omicron fears

Dec 8 (Reuters) - U.S. travel and leisure stocks surged on Wednesday after BioNtech SE (22UAy.DE) and Pfizer Inc (PFE.N) said a three-shot course of their COVID-19 vaccine was able to neutralize the new Omicron variant. Shares of U.S. airlines - including Delta Air Lines Inc (DAL.N), United Airlines Holdings...
INDUSTRY
Picture for U.S. travel stocks jump as new vaccine data eases Omicron fears
Benzinga

Pfizer/BioNTech COVID-19 Shot Provides Partial Protection Against Omicron, Study Shows

A small study in South Africa shows that the omicron variant can partially evade protection from two doses of Pfizer Inc (NYSE: PFE) / BioNTech SE's (NASDAQ: BNTX) COVID-19 vaccine. But the study did show that blood from people who had received two doses of the vaccine and had a prior infection were primarily able to neutralize the variant, thus suggesting booster doses of the vaccine could help to fend off the infection.
MEDICAL & BIOTECH
Picture for Pfizer/BioNTech COVID-19 Shot Provides Partial Protection Against Omicron, Study Shows
Entrepreneur

Three Pfizer Vaccine Shots Can Neutralize Omicron Variant

Pfizer Inc (NYSE:PFE) said Wednesday that three shots of its vaccine are effective at neutralizing the Omicron variant of COVID-19. The information stems from a laboratory test the pharma giant carried out, while it further announced that an Omicron-specific vaccine could be ready in March 2022. 25 Times More Antibodies.
INDUSTRY
Picture for Three Pfizer Vaccine Shots Can Neutralize Omicron Variant
TRENDING TOPICS

Asian shares catch global equities rally, but oil slips

HONG KONG, Dec 8 (Reuters) - Asian shares extended gains on Wednesday, continuing a global relief rally as markets found positive news in early reports about the potential impact of the Omicron variant, although overnight advances in oil prices began to peter out. "Markets are very sensitive to any slight...
STOCKS
Phramalive.com

Omicron reported in 57 countries, hospitalizations set to rise, WHO says

GENEVA, Dec 8 (Reuters) – The Omicron variant has been reported in 57 nations and the number of patients needing hospitalisation is likely to rise as it spreads, the World Health Organization said on Wednesday. The WHO, in its weekly epidemiological report, said more data was needed to assess...
WORLD

Brazil's real rallies over 1% ahead of interest rate decision

Dec 8 (Reuters) - Brazil's real rallied on Wednesday ahead of a widely anticipated interest rate hike by the central bank, while easing fears about the spread of the Omicron variant supported sentiment broadly in emerging markets. The real , was up 1.4% after gaining more than 1% in the...
BUSINESS

Why AMC Entertainment Shares Are Climbing Today

AMC Entertainment Holdings Inc (NYSE:AMC) is trading higher Wednesday amid strength in reopening names after Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) announced effectiveness of three doses of their vaccine against the omicron variant. The companies said preliminary laboratory studies demonstrated that three doses of the Pfizer-BioNTech COVID-19 vaccine neutralize...
MARKETS
chinadailyasia.com

UK PM apologizes for staff joking about lockdown party

British Prime Minister Boris Johnson leaves 10 Downing Street to attend the weekly Prime Minister's Questions at the Houses of Parliament, in London, Dec 8, 2021. (MATT DUNHAM/AP) British Prime Minister Boris Johnson apologised on Wednesday after a video surfaced showing his staff laughing and joking about a party in...
PUBLIC HEALTH
streetregister.com

3 Things to Watch -Breaking

Investing.com — On Wednesday, stocks traded flat after an initial surge of shares. This was due to new European restrictions that slow Omicron’s spread. However, there were also news reports suggesting the variant may be more severe than originally thought. Pfizer Inc (NASDAQ:), and BioNTechSE (NASDAQ:) stated that...
STOCKS
Medagadget.com

Eczema Therapeutics Market by 2021 Trends Progresses for Huge Profits at US$ 32,347.7 Mn With CAGR of 11.1% by Global Demand to 2028 | Coherent Market Insights

The global eczema therapeutics market is estimated to be valued at US$ 15,453.4 million in 2021 and is expected to exhibit a CAGR of 11.1% over the forecast period, as highlighted in a new report published by Coherent Market Insights. Request Here For PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/4630.
BUSINESS
chinadailyasia.com

Omicron threat may be countered with extra dose of vaccine

A healthcare worker holds a tray of syringes filled with the Pfizer-BioNTech vaccine for COVID-19 at a vaccination center in Munich, Germany, on Dec 2, 2021. (MICHAELA HANDREK-REHLE / BLOOMBERG) The earliest studies on Omicron are in and the glimpse they’re providing is cautiously optimistic: while vaccines like the one...
PHARMACEUTICALS
Medagadget.com

Anticoagulation Market Size is Projected to Reach USD 31696 Million by 2027 at 7.80% CAGR

The anticoagulation market is projected to reach USD 31,696.59 million by 2027 at a CAGR of 7.80% during the forecast period. The global anticoagulation market is growing steadily due to the rising demand for anticoagulants, which creates lucrative growth opportunities for the number of players coming forward with new and better products. The value chain analysis of the anticoagulation market comprises four major components: research & development and designing, manufacturing the products, distribution & sales, and post-sales services.
MARKETS
YOU MAY ALSO LIKE